Boston Scientific Announces Cash Tender Offer for up to $2.5 Billion of Its Outstanding Debt Securities

/PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE:BSX) today announced the commencement of a cash tender offer (the "Tender Offer") for up to...

Related Keywords

Boston ,Massachusetts ,United States ,Russia ,Ukraine ,Lauren Tengler ,Kate Haranis ,Boston Scientific Corporation ,Bloomberg ,Barclays Capital Inc ,Boston Scientific ,Boston Scientific Corporation The Company ,Exchange Commission ,King Co Inc ,Liability Management Group ,Citigroup Global Markets Inc ,None Of The Company ,Maximum Principal ,Tender Offer ,Priority Level ,Tender Payment ,Senior Notes ,Aggregate Maximum Principal ,Aggregate Maximum Principal Amount ,Acceptance Priority Level ,Acceptance Sublimits ,Acceptance Sublimit ,Total Consideration ,Early Tender Date ,Fixed Spread ,Early Tender Payment ,Eastern Time ,Expiration Date ,Tender Offer Consideration ,Price Determination ,Early Tender ,Acceptance Priority Levels ,Financing Condition ,Early Settlement Date ,Final Settlement Date ,Price Determination Date ,Capital Inc ,Bofa Securities ,Citigroup Global Markets ,Information Agent ,Lead Dealer Managers ,Risk Factors ,Annual Report ,Quarterly Reports ,